Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17115072 | KIT FOR PREVENTING DISTAL EMBOLISM DURING ENDOVASCULAR INTERVENTIONS AND METHOD FOR PREVENTING DISTAL EMBOLISM DURING ENDOVASCULAR INTERVENTIONS USING SAID KIT | December 2020 | May 2023 | Abandon | 29 | 1 | 0 | No | No |
| 17052846 | INSERTION TYPE DRUG INJECTION DEVICE | November 2020 | November 2022 | Allow | 25 | 3 | 0 | Yes | No |
| 17052532 | A CATHETER MOUNTING ARRANGEMENT FOR SECURING A CATHETER TO A PATIENT AND A METHOD OF MAINTAINING THE SECURING AND INTEGRITY IN FLUID FLOW WITHIN THE CATHETER WHILE MOUNTED TO THE PATIENT | November 2020 | October 2023 | Allow | 36 | 1 | 0 | No | No |
| 17085325 | Catheter Securing Devices and Methods | October 2020 | April 2023 | Abandon | 29 | 1 | 0 | No | No |
| 17082346 | SYSTEMS AND METHODS FOR EXPANDING A CATHETER | October 2020 | July 2022 | Allow | 20 | 1 | 0 | No | No |
| 16949192 | NASOGASTRIC TUBE STABILIZATION SYSTEM | October 2020 | April 2024 | Allow | 42 | 3 | 0 | Yes | No |
| 17072867 | DISPOSABLE MEDICAL DEVICE INTRODUCTION SYSTEM | October 2020 | April 2023 | Allow | 30 | 1 | 0 | No | No |
| 17061761 | DIRECTIONAL BALLOON TRANSSEPTAL INSERTION DEVICE FOR MEDICAL PROCEDURES WITH IMPROVED HANDLE | October 2020 | January 2023 | Allow | 28 | 0 | 1 | No | No |
| 17044184 | SYSTEM AND METHOD FOR ULTRASONIC BLADDER THERAPEUTIC AGENT DELIVERY | September 2020 | August 2022 | Allow | 22 | 1 | 1 | Yes | No |
| 17036346 | DRUG SOLUTION ADMINISTRATION DEVICE | September 2020 | August 2023 | Abandon | 34 | 1 | 1 | No | No |
| 17031478 | Integrated Acute Central Venous Catheter and Peripherally Inserted Venous Catheter | September 2020 | September 2022 | Allow | 23 | 1 | 0 | No | No |
| 17030058 | MEDICAL CONNECTORS HAVING INTEGRATED ADHESIVE BACKING | September 2020 | February 2023 | Allow | 29 | 2 | 1 | Yes | No |
| 17026557 | STRAIN RELIEF AND METHODS OF USE THEREOF | September 2020 | May 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 16982768 | MEDICAL TUBE HOLDER | September 2020 | July 2022 | Allow | 22 | 2 | 0 | No | No |
| 17017276 | EXPANDABLE MOUTH CATHETER | September 2020 | July 2022 | Allow | 22 | 1 | 0 | No | No |
| 16977904 | Syringe Stopper and Plunger Rod Arrangement for a Syringe Assembly | September 2020 | February 2023 | Allow | 30 | 1 | 1 | No | No |
| 17009058 | Catheter Stabilizing Device | September 2020 | April 2023 | Abandon | 32 | 2 | 0 | No | Yes |
| 16975158 | CATHETER SECUREMENT DEVICE | August 2020 | September 2022 | Abandon | 25 | 1 | 0 | No | No |
| 16997318 | Shuttle Nib for Control of Stopper During Injection | August 2020 | June 2023 | Allow | 34 | 1 | 0 | No | No |
| 16971115 | METHOD AND APPARATUS FOR RECTAL ANAESTHESIA | August 2020 | July 2022 | Allow | 23 | 0 | 1 | Yes | No |
| 16970041 | Medical Device for Injecting a Composition Provided with a Safety Needle Cover | August 2020 | April 2022 | Allow | 20 | 1 | 0 | No | No |
| 16947280 | CLOSED CIRCUIT DRESSING SYSTEM FOR PICC SITES AND PICC LINES | July 2020 | July 2022 | Allow | 23 | 2 | 0 | Yes | No |
| 16936754 | COMBINED INFUSION SET AND SENSOR | July 2020 | August 2022 | Allow | 25 | 1 | 1 | Yes | No |
| 16771770 | CONTROL OF EXOGENOUS AGENT CHARACTERISTICS IN MICROBUBBLE-MEDIATED ULTRASOUND PROCEDURES | June 2020 | April 2024 | Allow | 46 | 3 | 0 | Yes | No |
| 16891053 | Personal Hygiene Device | June 2020 | April 2022 | Allow | 23 | 2 | 0 | Yes | No |
| 16881094 | GUIDEWIRE | May 2020 | June 2023 | Abandon | 36 | 2 | 0 | Yes | No |
| 16870516 | ORAL-HYDRATION SYSTEM, METHOD, AND KIT | May 2020 | March 2023 | Abandon | 34 | 0 | 1 | No | No |
| 16758636 | JACKETED CATHETER PROBES AND METHODS OF USE FOR INFUSION | April 2020 | April 2023 | Abandon | 36 | 0 | 1 | No | No |
| 16836580 | STRAIN RELIEF AND METHODS OF USE THEREOF | March 2020 | November 2022 | Abandon | 32 | 2 | 0 | No | No |
| 16818334 | METHODS AND DEVICES FOR TRANSCERVICAL TREATMENT OF ENDOMETRIAL CANCER AND HYPERPLASIA | March 2020 | August 2022 | Allow | 29 | 1 | 1 | Yes | No |
| 16812210 | ACTUATING ELEMENTS FOR BENDING MEDICAL DEVICES | March 2020 | April 2022 | Allow | 26 | 1 | 0 | No | No |
| 16643598 | SURGICAL INSTRUMENT FOR SUCTION AND IRRIGATION | March 2020 | April 2022 | Allow | 25 | 1 | 0 | No | No |
| 16779854 | PLASTER FOR SECURING A TUBE | February 2020 | March 2022 | Allow | 25 | 1 | 0 | No | No |
| 16750150 | SMOKE EVACUATING TISSUE GUARD FOR TISSUE REMOVAL AND OTHER SURGICAL PROCEDURES | January 2020 | September 2023 | Allow | 44 | 0 | 0 | No | No |
| 16734906 | DEVICE FOR CONVEYING BIOLOGICAL MATERIAL | January 2020 | October 2022 | Allow | 34 | 1 | 1 | No | No |
| 16732796 | SKELETAL MUSCLE STIMULATION FOR GLUCOSE CONTROL | January 2020 | November 2023 | Abandon | 46 | 3 | 0 | No | No |
| 16725069 | DRUG DELIVERY SYSTEMS AND METHODS WITH PRESSURE SENSITIVE CONTROL | December 2019 | August 2022 | Allow | 32 | 2 | 1 | Yes | No |
| 16625543 | CATHETER DEVICES WITH BLOOD CONTROL SYSTEMS AND RELATED METHODS | December 2019 | November 2022 | Allow | 35 | 2 | 0 | Yes | Yes |
| 16697301 | Removal member for removing a needle protective cap | November 2019 | May 2022 | Allow | 30 | 1 | 1 | No | No |
| 16688111 | ISOLATED INTRAVASCULAR TREATMENT WITH PERFUSION BYPASS | November 2019 | November 2023 | Abandon | 48 | 2 | 1 | Yes | No |
| 16613428 | ENEMA DEVICE FOR WASHING LARGE INTESTINE | November 2019 | May 2022 | Abandon | 30 | 1 | 0 | No | No |
| 16558768 | CONFIGURABLE CONTROL HANDLE FOR CATHETERS AND OTHER SURGICAL TOOL | September 2019 | December 2022 | Allow | 40 | 2 | 0 | No | No |
| 16556839 | Cannula | August 2019 | August 2022 | Allow | 36 | 1 | 0 | Yes | No |
| 16538433 | SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICES | August 2019 | July 2022 | Allow | 35 | 1 | 0 | No | No |
| 16526119 | Medical Device Position Notification System | July 2019 | December 2022 | Abandon | 41 | 2 | 0 | No | No |
| 16503384 | APPARATUS AND METHODS FOR LUBRICATING DEVICES INTRODUCED INTO A BODY OF A PATIENT | July 2019 | August 2022 | Allow | 38 | 1 | 0 | Yes | No |
| 16449290 | DISPOSABLE NASAL AND EYE WASH DISPENSER | June 2019 | May 2023 | Allow | 47 | 1 | 1 | Yes | No |
| 16449072 | ANNULUS PLANE CATHETER | June 2019 | October 2022 | Allow | 39 | 0 | 1 | Yes | No |
| 16468447 | MULTI-DOSE DISPENSER | June 2019 | December 2021 | Allow | 30 | 1 | 0 | Yes | No |
| 16466913 | FILTER ASSEMBLY | June 2019 | August 2023 | Allow | 50 | 4 | 1 | No | No |
| 16319609 | GUIDE WIRE FOR USE IN TUBULAR MEDICAL PROBES, IN PARTICULAR FOR NUTRITIONAL THERAPY | January 2019 | January 2023 | Abandon | 48 | 4 | 0 | No | No |
| 16213510 | MULTI-FUNCTION CANNULATED SURGICAL DEVICE AND SYSTEMS THEREOF | December 2018 | October 2022 | Abandon | 46 | 1 | 0 | No | No |
| 16071428 | CANNULA AND INFUSION DEVICES | July 2018 | February 2022 | Allow | 43 | 2 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner STATON, PHOEBE ANNE.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner STATON, PHOEBE ANNE works in Art Unit 3783 and has examined 53 patent applications in our dataset. With an allowance rate of 71.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 32 months.
Examiner STATON, PHOEBE ANNE's allowance rate of 71.7% places them in the 36% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by STATON, PHOEBE ANNE receive 1.40 office actions before reaching final disposition. This places the examiner in the 19% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by STATON, PHOEBE ANNE is 32 months. This places the examiner in the 53% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +31.1% benefit to allowance rate for applications examined by STATON, PHOEBE ANNE. This interview benefit is in the 78% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 35.7% of applications are subsequently allowed. This success rate is in the 81% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 46.2% of cases where such amendments are filed. This entry rate is in the 71% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 33.3% are granted (fully or in part). This grant rate is in the 21% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.